An Irish father fighting to prove an anti-acne drug led to his son’s suicide spearheaded a real shift in culture in the EU towards transparency, said the EU ombudsman.

EU medical authorities have been sharply criticised by the European Ombudsman over their refusal to give access to an Irish citizen who sought information on adverse reactions to the controversial anti-acne drug, Roaccutane.